A NEW CRYSTALLINE FORM OF 4- (5- { (IR) -1- 5- (3- CHLOROPHENYL) ISOXAZOL-3-YL ETHOXY } -4-METHYL-4H-L, 2, 4- TRIAZOL-3-YL) PYRIDINE.

摘要

The present invention relates to a novel crystalline form of 4- (5-{ (IR) -1- [5- (3-chlorophenyl) isoxazol-3-yl] ethoxy } -4- methyl-4H-l, 2, 4-triazol-3-yl) pyridine. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it.